Biomarker FM Architecture Landscape

EHR & Trial Data in Biomarker Discovery

This section outlines the foundational data inputs powering next-generation biomarker discovery. Biopharma companies are increasingly leveraging Foundation Models (FMs) to process vast, unstructured datasets. By unifying Electronic Health Records (EHR), clinical trial readouts, and multi-omics data, researchers can identify novel prognostic and predictive biomarkers that were previously hidden in siloed systems.

EHR Data Processing

80%

Of healthcare data is unstructured clinical text, unlocked by NLP FMs.

Trial Data Utility

3x

Increase in target validation speed using cross-trial embedded analysis.

Biomarker Yield

+45%

Higher candidate yield when combining omics with longitudinal EHRs.

Data Source Distribution for Biomarker FMs

Proportional breakdown of datasets typically ingested to train and fine-tune biopharma models for biomarker identification.

Cloud & Enterprise Data Platforms

Explore the infrastructure supporting complex FM workloads. Biopharma relies heavily on major cloud providers for scalable compute, paired with enterprise data platforms to manage the transition from raw data lakes to AI-ready structures. Understanding the interplay between Databricks, Snowflake, and native cloud services is critical for deploying biomarker models.

Cloud Provider Adoption in Biopharma

Relative market penetration for healthcare-specific cloud ecosystems.

AWS: Leads with HealthLake for FHIR-formatted EHRs.
Azure: Preferred for enterprise IT integration and Azure OpenAI FMs.
GCP: Excels in deep ML tooling and Healthcare API integration.

Enterprise Platforms: The Data Layer

How biopharma manages vast EHR and trial datasets before FM ingestion.

Databricks (Lakehouse) ▼

Primary Use: Unified Analytics & ML Workflows.

Highly preferred by biopharma data scientists for processing messy, unstructured data (like raw EHR notes and genomic sequences). The Delta Lake architecture allows applying ACID transactions to data lakes. Excellent for running Spark ML and orchestrating the fine-tuning of Foundation Models directly on the data.

Snowflake (Data Cloud) ▼

Vector Databases ▼

Preferred Foundation Models in Biopharma

Filter and explore the specific AI models utilized for biomarker development. Biopharma employs a mix of domain-specific language models for clinical text and specialized biological models for proteomics and genomics. Use the filters below to categorize models by their primary data modality.

Biomarker Development Workflow

This interactive process flow illustrates how raw patient and trial data move through enterprise platforms and foundation models to yield actionable biomarker insights. Click on each step to view the technologies involved at that stage.

📂

1. Data Ingestion

➤

⯆

🗃

2. Enterprise Storage

➤

⯆

AI Engine

⚙

3. FM Processing

➤

⯆

🎯

4. Biomarker Output

Select a workflow stage above

Click the cards to see detailed information regarding platform usage, model implementation, and data handling at each step of the biomarker discovery process.